nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Nucleic Acid Synthesis Inhibitors—Capecitabine—esophageal cancer	0.627	1	CiPCiCtD
Azacitidine—CDA—Capecitabine—esophageal cancer	0.305	1	CbGbCtD
Azacitidine—CDA—Pyrimidine salvage reactions—TYMP—esophageal cancer	0.00432	0.161	CbGpPWpGaD
Azacitidine—CDA—Pyrimidine metabolism—TYMP—esophageal cancer	0.00197	0.0736	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00182	0.0681	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00153	0.057	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00106	0.0395	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—ARID1A—esophageal cancer	0.000986	0.0368	CbGpPWpGaD
Azacitidine—DNMT3A—digestive system—esophageal cancer	0.00093	0.15	CbGeAlD
Azacitidine—CDA—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000862	0.0322	CbGpPWpGaD
Azacitidine—DNMT3A—DNA methylation—HIST1H2BM—esophageal cancer	0.000803	0.03	CbGpPWpGaD
Azacitidine—DNMT3A—lung—esophageal cancer	0.000776	0.125	CbGeAlD
Azacitidine—CDA—Nucleotide metabolism—TYMP—esophageal cancer	0.000767	0.0287	CbGpPWpGaD
Azacitidine—DNMT1—epithelium—esophageal cancer	0.000739	0.119	CbGeAlD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—HIST1H2BM—esophageal cancer	0.000728	0.0272	CbGpPWpGaD
Azacitidine—DNMT1—bronchus—esophageal cancer	0.000728	0.117	CbGeAlD
Azacitidine—DNMT1—trachea—esophageal cancer	0.000653	0.105	CbGeAlD
Azacitidine—DNMT1—digestive system—esophageal cancer	0.000562	0.0905	CbGeAlD
Azacitidine—DNMT3A—Chromatin modifying enzymes—KDM6A—esophageal cancer	0.000556	0.0208	CbGpPWpGaD
Azacitidine—DNMT1—DNA methylation—HIST1H2BM—esophageal cancer	0.000542	0.0203	CbGpPWpGaD
Azacitidine—DNMT3A—lymph node—esophageal cancer	0.000531	0.0855	CbGeAlD
Azacitidine—CDA—lymph node—esophageal cancer	0.000502	0.0808	CbGeAlD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—HIST1H2BM—esophageal cancer	0.000492	0.0184	CbGpPWpGaD
Azacitidine—DNMT1—lung—esophageal cancer	0.00047	0.0756	CbGeAlD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—HIST1H2BM—esophageal cancer	0.000467	0.0174	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—SMAD4—esophageal cancer	0.000437	0.0163	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID1A—esophageal cancer	0.000421	0.0157	CbGpPWpGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—HIST1H2BM—esophageal cancer	0.000364	0.0136	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—HIST1H2BM—esophageal cancer	0.000356	0.0133	CbGpPWpGaD
Azacitidine—DNMT1—lymph node—esophageal cancer	0.000321	0.0517	CbGeAlD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—HIST1H2BM—esophageal cancer	0.000316	0.0118	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—HIST1H2BM—esophageal cancer	0.000295	0.011	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—ABL1—esophageal cancer	0.000294	0.011	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.000285	0.0106	CbGpPWpGaD
Azacitidine—Adenosine monophosphate—PDE4D—esophageal cancer	0.000275	0.37	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—BCL2—esophageal cancer	0.000252	0.0094	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ACTB—esophageal cancer	0.000251	0.00936	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—esophageal cancer	0.000245	0.00913	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.000235	0.00879	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ABL1—esophageal cancer	0.00023	0.31	CrCbGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000229	0.00855	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MET—esophageal cancer	0.000218	0.00813	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—esophageal cancer	0.000216	0.00807	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1A—esophageal cancer	0.000209	0.00781	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—EP300—esophageal cancer	0.000199	0.00743	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CREBBP—esophageal cancer	0.00019	0.0071	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—RB1—esophageal cancer	0.000189	0.00707	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—esophageal cancer	0.000188	0.00702	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—esophageal cancer	0.000173	0.00647	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—esophageal cancer	0.000166	0.00622	CbGpPWpGaD
Azacitidine—Injection site reaction—Capecitabine—esophageal cancer	0.00016	0.00463	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000158	0.00458	CcSEcCtD
Azacitidine—Melaena—Capecitabine—esophageal cancer	0.000157	0.00454	CcSEcCtD
Azacitidine—Pleural effusion—Methotrexate—esophageal cancer	0.000156	0.00452	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.000152	0.00567	CbGpPWpGaD
Azacitidine—Dehydration—Cisplatin—esophageal cancer	0.000147	0.00426	CcSEcCtD
Azacitidine—Petechiae—Methotrexate—esophageal cancer	0.000145	0.00421	CcSEcCtD
Azacitidine—Ecchymosis—Capecitabine—esophageal cancer	0.000145	0.00421	CcSEcCtD
Azacitidine—Neoplasm—Capecitabine—esophageal cancer	0.000145	0.00421	CcSEcCtD
Azacitidine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000145	0.00418	CcSEcCtD
Azacitidine—Hypokalaemia—Cisplatin—esophageal cancer	0.000144	0.00417	CcSEcCtD
Azacitidine—Cramp muscle—Cisplatin—esophageal cancer	0.000142	0.00413	CcSEcCtD
Azacitidine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000142	0.0041	CcSEcCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—esophageal cancer	0.000141	0.00525	CbGpPWpGaD
Azacitidine—Sepsis—Capecitabine—esophageal cancer	0.000139	0.00404	CcSEcCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN1A—esophageal cancer	0.000136	0.00508	CbGpPWpGaD
Azacitidine—Sweating increased—Cisplatin—esophageal cancer	0.000133	0.00386	CcSEcCtD
Azacitidine—Vascular purpura—Capecitabine—esophageal cancer	0.00013	0.00378	CcSEcCtD
Azacitidine—Pancytopenia—Cisplatin—esophageal cancer	0.00013	0.00376	CcSEcCtD
Azacitidine—Herpes simplex—Methotrexate—esophageal cancer	0.00013	0.00376	CcSEcCtD
Azacitidine—Hepatic failure—Capecitabine—esophageal cancer	0.00013	0.00376	CcSEcCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—EP300—esophageal cancer	0.000129	0.00483	CbGpPWpGaD
Azacitidine—Inflammation—Methotrexate—esophageal cancer	0.000123	0.00357	CcSEcCtD
Azacitidine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000123	0.00356	CcSEcCtD
Azacitidine—Purpura—Capecitabine—esophageal cancer	0.000121	0.0035	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—SMG6—esophageal cancer	0.00012	0.00448	CbGpPWpGaD
Azacitidine—Renal failure—Cisplatin—esophageal cancer	0.00012	0.00347	CcSEcCtD
Azacitidine—Cardiac failure—Capecitabine—esophageal cancer	0.00012	0.00346	CcSEcCtD
Azacitidine—Lethargy—Capecitabine—esophageal cancer	0.000119	0.00345	CcSEcCtD
Azacitidine—Stomatitis—Cisplatin—esophageal cancer	0.000119	0.00344	CcSEcCtD
Azacitidine—Melaena—Methotrexate—esophageal cancer	0.000117	0.00338	CcSEcCtD
Azacitidine—Pain in extremity—Capecitabine—esophageal cancer	0.000117	0.00338	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000117	0.00338	CcSEcCtD
Azacitidine—Adenosine triphosphate—ABCC2—esophageal cancer	0.000116	0.156	CrCbGaD
Azacitidine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000115	0.00334	CcSEcCtD
Azacitidine—CDA—Metabolism—BLVRB—esophageal cancer	0.000115	0.0043	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC52A3—esophageal cancer	0.000115	0.0043	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000113	0.00421	CbGpPWpGaD
Azacitidine—Coma—Methotrexate—esophageal cancer	0.000109	0.00316	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000109	0.00407	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CREBBP—esophageal cancer	0.000109	0.00405	CbGpPWpGaD
Azacitidine—Dehydration—Capecitabine—esophageal cancer	0.000108	0.00314	CcSEcCtD
Azacitidine—Neoplasm—Methotrexate—esophageal cancer	0.000108	0.00313	CcSEcCtD
Azacitidine—Ecchymosis—Methotrexate—esophageal cancer	0.000108	0.00313	CcSEcCtD
Azacitidine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000108	0.00313	CcSEcCtD
Azacitidine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000108	0.00311	CcSEcCtD
Azacitidine—Urethral disorder—Cisplatin—esophageal cancer	0.000107	0.00311	CcSEcCtD
Azacitidine—Dry skin—Capecitabine—esophageal cancer	0.000107	0.0031	CcSEcCtD
Azacitidine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000107	0.00308	CcSEcCtD
Azacitidine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000107	0.00308	CcSEcCtD
Azacitidine—Hypokalaemia—Capecitabine—esophageal cancer	0.000106	0.00307	CcSEcCtD
Azacitidine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000104	0.00302	CcSEcCtD
Azacitidine—Sepsis—Methotrexate—esophageal cancer	0.000104	0.00301	CcSEcCtD
Azacitidine—Muscular weakness—Capecitabine—esophageal cancer	0.000103	0.00298	CcSEcCtD
Azacitidine—Eye disorder—Cisplatin—esophageal cancer	0.000102	0.00296	CcSEcCtD
Azacitidine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000102	0.00295	CcSEcCtD
Azacitidine—Cardiac disorder—Cisplatin—esophageal cancer	0.000102	0.00294	CcSEcCtD
Azacitidine—Abdominal distension—Capecitabine—esophageal cancer	0.000101	0.00294	CcSEcCtD
Azacitidine—Dysphagia—Capecitabine—esophageal cancer	0.000101	0.00292	CcSEcCtD
Azacitidine—Immune system disorder—Cisplatin—esophageal cancer	9.89e-05	0.00286	CcSEcCtD
Azacitidine—Mediastinal disorder—Cisplatin—esophageal cancer	9.87e-05	0.00286	CcSEcCtD
Azacitidine—Sweating increased—Capecitabine—esophageal cancer	9.82e-05	0.00284	CcSEcCtD
Azacitidine—CDA—Metabolism—CA1—esophageal cancer	9.78e-05	0.00365	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC10A2—esophageal cancer	9.78e-05	0.00365	CbGpPWpGaD
Azacitidine—Bronchitis—Capecitabine—esophageal cancer	9.7e-05	0.00281	CcSEcCtD
Azacitidine—Alopecia—Cisplatin—esophageal cancer	9.67e-05	0.0028	CcSEcCtD
Azacitidine—Hepatic failure—Methotrexate—esophageal cancer	9.66e-05	0.0028	CcSEcCtD
Azacitidine—Pancytopenia—Capecitabine—esophageal cancer	9.57e-05	0.00277	CcSEcCtD
Azacitidine—Malnutrition—Cisplatin—esophageal cancer	9.53e-05	0.00276	CcSEcCtD
Azacitidine—Erythema—Cisplatin—esophageal cancer	9.53e-05	0.00276	CcSEcCtD
Azacitidine—Neutropenia—Capecitabine—esophageal cancer	9.43e-05	0.00273	CcSEcCtD
Azacitidine—Dysuria—Capecitabine—esophageal cancer	9.43e-05	0.00273	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Capecitabine—esophageal cancer	9.37e-05	0.00271	CcSEcCtD
Azacitidine—Muscle spasms—Cisplatin—esophageal cancer	9.16e-05	0.00265	CcSEcCtD
Azacitidine—Weight decreased—Capecitabine—esophageal cancer	9.12e-05	0.00264	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—NR1I2—esophageal cancer	9.1e-05	0.0034	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	9.04e-05	0.00338	CbGpPWpGaD
Azacitidine—Pneumonia—Capecitabine—esophageal cancer	9.04e-05	0.00262	CcSEcCtD
Azacitidine—Infestation NOS—Capecitabine—esophageal cancer	8.99e-05	0.0026	CcSEcCtD
Azacitidine—Infestation—Capecitabine—esophageal cancer	8.99e-05	0.0026	CcSEcCtD
Azacitidine—Depression—Capecitabine—esophageal cancer	8.96e-05	0.0026	CcSEcCtD
Azacitidine—CDA—Metabolism—CA2—esophageal cancer	8.95e-05	0.00334	CbGpPWpGaD
Azacitidine—Lethargy—Methotrexate—esophageal cancer	8.86e-05	0.00257	CcSEcCtD
Azacitidine—Ill-defined disorder—Cisplatin—esophageal cancer	8.84e-05	0.00256	CcSEcCtD
Azacitidine—Renal failure—Capecitabine—esophageal cancer	8.84e-05	0.00256	CcSEcCtD
Azacitidine—Anaemia—Cisplatin—esophageal cancer	8.81e-05	0.00255	CcSEcCtD
Azacitidine—Stomatitis—Capecitabine—esophageal cancer	8.76e-05	0.00254	CcSEcCtD
Azacitidine—Urinary tract infection—Capecitabine—esophageal cancer	8.74e-05	0.00253	CcSEcCtD
Azacitidine—Malaise—Cisplatin—esophageal cancer	8.59e-05	0.00249	CcSEcCtD
Azacitidine—Haematuria—Capecitabine—esophageal cancer	8.57e-05	0.00248	CcSEcCtD
Azacitidine—Leukopenia—Cisplatin—esophageal cancer	8.53e-05	0.00247	CcSEcCtD
Azacitidine—Hepatobiliary disease—Capecitabine—esophageal cancer	8.5e-05	0.00246	CcSEcCtD
Azacitidine—Epistaxis—Capecitabine—esophageal cancer	8.48e-05	0.00245	CcSEcCtD
Azacitidine—Agranulocytosis—Capecitabine—esophageal cancer	8.39e-05	0.00243	CcSEcCtD
Azacitidine—CDA—Metabolism—PLCE1—esophageal cancer	8.32e-05	0.00311	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ADH7—esophageal cancer	8.32e-05	0.00311	CbGpPWpGaD
Azacitidine—Convulsion—Cisplatin—esophageal cancer	8.26e-05	0.00239	CcSEcCtD
Azacitidine—Myalgia—Cisplatin—esophageal cancer	8.11e-05	0.00235	CcSEcCtD
Azacitidine—Haemoglobin—Capecitabine—esophageal cancer	8.11e-05	0.00235	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—SMG6—esophageal cancer	8.11e-05	0.00303	CbGpPWpGaD
Azacitidine—Rhinitis—Capecitabine—esophageal cancer	8.09e-05	0.00234	CcSEcCtD
Azacitidine—Anxiety—Cisplatin—esophageal cancer	8.09e-05	0.00234	CcSEcCtD
Azacitidine—Haemorrhage—Capecitabine—esophageal cancer	8.07e-05	0.00234	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	8.06e-05	0.00233	CcSEcCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—esophageal cancer	8.03e-05	0.003	CbGpPWpGaD
Azacitidine—Hypoaesthesia—Capecitabine—esophageal cancer	8.03e-05	0.00232	CcSEcCtD
Azacitidine—Discomfort—Cisplatin—esophageal cancer	8.02e-05	0.00232	CcSEcCtD
Azacitidine—Pharyngitis—Capecitabine—esophageal cancer	8.01e-05	0.00232	CcSEcCtD
Azacitidine—Gemcitabine—ABCB1—esophageal cancer	7.97e-05	0.107	CrCbGaD
Azacitidine—Urinary tract disorder—Capecitabine—esophageal cancer	7.97e-05	0.00231	CcSEcCtD
Azacitidine—Oedema peripheral—Capecitabine—esophageal cancer	7.95e-05	0.0023	CcSEcCtD
Azacitidine—Connective tissue disorder—Capecitabine—esophageal cancer	7.93e-05	0.0023	CcSEcCtD
Azacitidine—Urethral disorder—Capecitabine—esophageal cancer	7.91e-05	0.00229	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—HIST1H2BM—esophageal cancer	7.8e-05	0.00291	CbGpPWpGaD
Azacitidine—Oedema—Cisplatin—esophageal cancer	7.78e-05	0.00225	CcSEcCtD
Azacitidine—Anaphylactic shock—Cisplatin—esophageal cancer	7.78e-05	0.00225	CcSEcCtD
Azacitidine—Infection—Cisplatin—esophageal cancer	7.73e-05	0.00224	CcSEcCtD
Azacitidine—Nervous system disorder—Cisplatin—esophageal cancer	7.63e-05	0.00221	CcSEcCtD
Azacitidine—Thrombocytopenia—Cisplatin—esophageal cancer	7.62e-05	0.0022	CcSEcCtD
Azacitidine—Tachycardia—Cisplatin—esophageal cancer	7.59e-05	0.0022	CcSEcCtD
Azacitidine—Skin disorder—Cisplatin—esophageal cancer	7.55e-05	0.00219	CcSEcCtD
Azacitidine—Eye disorder—Capecitabine—esophageal cancer	7.54e-05	0.00218	CcSEcCtD
Azacitidine—Hyperhidrosis—Cisplatin—esophageal cancer	7.52e-05	0.00218	CcSEcCtD
Azacitidine—Cardiac disorder—Capecitabine—esophageal cancer	7.49e-05	0.00217	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	7.43e-05	0.00277	CbGpPWpGaD
Azacitidine—Anorexia—Cisplatin—esophageal cancer	7.41e-05	0.00215	CcSEcCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—EP300—esophageal cancer	7.39e-05	0.00276	CbGpPWpGaD
Azacitidine—Angiopathy—Capecitabine—esophageal cancer	7.32e-05	0.00212	CcSEcCtD
Azacitidine—CDA—Metabolism—ADH1B—esophageal cancer	7.29e-05	0.00272	CbGpPWpGaD
Azacitidine—Immune system disorder—Capecitabine—esophageal cancer	7.29e-05	0.00211	CcSEcCtD
Azacitidine—Mediastinal disorder—Capecitabine—esophageal cancer	7.27e-05	0.00211	CcSEcCtD
Azacitidine—Hypotension—Cisplatin—esophageal cancer	7.27e-05	0.0021	CcSEcCtD
Azacitidine—Chills—Capecitabine—esophageal cancer	7.24e-05	0.0021	CcSEcCtD
Azacitidine—Alopecia—Capecitabine—esophageal cancer	7.13e-05	0.00206	CcSEcCtD
Azacitidine—Pancytopenia—Methotrexate—esophageal cancer	7.13e-05	0.00206	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	7.09e-05	0.00205	CcSEcCtD
Azacitidine—Mental disorder—Capecitabine—esophageal cancer	7.07e-05	0.00205	CcSEcCtD
Azacitidine—Malnutrition—Capecitabine—esophageal cancer	7.02e-05	0.00203	CcSEcCtD
Azacitidine—Erythema—Capecitabine—esophageal cancer	7.02e-05	0.00203	CcSEcCtD
Azacitidine—Neutropenia—Methotrexate—esophageal cancer	7.02e-05	0.00203	CcSEcCtD
Azacitidine—Dysuria—Methotrexate—esophageal cancer	7.02e-05	0.00203	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Methotrexate—esophageal cancer	6.98e-05	0.00202	CcSEcCtD
Azacitidine—CDA—Metabolism—TYMP—esophageal cancer	6.97e-05	0.0026	CbGpPWpGaD
Azacitidine—Dyspnoea—Cisplatin—esophageal cancer	6.93e-05	0.00201	CcSEcCtD
Azacitidine—Back pain—Capecitabine—esophageal cancer	6.79e-05	0.00197	CcSEcCtD
Azacitidine—CDA—Metabolism—CYP26A1—esophageal cancer	6.78e-05	0.00253	CbGpPWpGaD
Azacitidine—Decreased appetite—Cisplatin—esophageal cancer	6.76e-05	0.00196	CcSEcCtD
Azacitidine—Muscle spasms—Capecitabine—esophageal cancer	6.75e-05	0.00196	CcSEcCtD
Azacitidine—Pneumonia—Methotrexate—esophageal cancer	6.73e-05	0.00195	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Cisplatin—esophageal cancer	6.71e-05	0.00194	CcSEcCtD
Azacitidine—Infestation—Methotrexate—esophageal cancer	6.69e-05	0.00194	CcSEcCtD
Azacitidine—Infestation NOS—Methotrexate—esophageal cancer	6.69e-05	0.00194	CcSEcCtD
Azacitidine—Depression—Methotrexate—esophageal cancer	6.67e-05	0.00193	CcSEcCtD
Azacitidine—Pain—Cisplatin—esophageal cancer	6.65e-05	0.00193	CcSEcCtD
Azacitidine—CDA—Metabolism—ALOX15—esophageal cancer	6.61e-05	0.00247	CbGpPWpGaD
Azacitidine—Renal failure—Methotrexate—esophageal cancer	6.58e-05	0.0019	CcSEcCtD
Azacitidine—Stomatitis—Methotrexate—esophageal cancer	6.52e-05	0.00189	CcSEcCtD
Azacitidine—Ill-defined disorder—Capecitabine—esophageal cancer	6.52e-05	0.00189	CcSEcCtD
Azacitidine—Anaemia—Capecitabine—esophageal cancer	6.49e-05	0.00188	CcSEcCtD
Azacitidine—Feeling abnormal—Cisplatin—esophageal cancer	6.41e-05	0.00186	CcSEcCtD
Azacitidine—Haematuria—Methotrexate—esophageal cancer	6.38e-05	0.00185	CcSEcCtD
Azacitidine—Malaise—Capecitabine—esophageal cancer	6.33e-05	0.00183	CcSEcCtD
Azacitidine—Hepatobiliary disease—Methotrexate—esophageal cancer	6.33e-05	0.00183	CcSEcCtD
Azacitidine—Epistaxis—Methotrexate—esophageal cancer	6.31e-05	0.00183	CcSEcCtD
Azacitidine—CDA—Metabolism—TPI1—esophageal cancer	6.3e-05	0.00235	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTO1—esophageal cancer	6.3e-05	0.00235	CbGpPWpGaD
Azacitidine—Syncope—Capecitabine—esophageal cancer	6.3e-05	0.00182	CcSEcCtD
Azacitidine—Leukopenia—Capecitabine—esophageal cancer	6.29e-05	0.00182	CcSEcCtD
Azacitidine—Agranulocytosis—Methotrexate—esophageal cancer	6.24e-05	0.00181	CcSEcCtD
Azacitidine—Loss of consciousness—Capecitabine—esophageal cancer	6.17e-05	0.00179	CcSEcCtD
Azacitidine—Body temperature increased—Cisplatin—esophageal cancer	6.15e-05	0.00178	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—NR1I2—esophageal cancer	6.14e-05	0.00229	CbGpPWpGaD
Azacitidine—Cough—Capecitabine—esophageal cancer	6.13e-05	0.00177	CcSEcCtD
Azacitidine—Hypertension—Capecitabine—esophageal cancer	6.06e-05	0.00176	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—PSME1—esophageal cancer	6.06e-05	0.00226	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PSME2—esophageal cancer	6.06e-05	0.00226	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ALDOB—esophageal cancer	6.04e-05	0.00226	CbGpPWpGaD
Azacitidine—Haemoglobin—Methotrexate—esophageal cancer	6.04e-05	0.00175	CcSEcCtD
Azacitidine—Haemorrhage—Methotrexate—esophageal cancer	6.01e-05	0.00174	CcSEcCtD
Azacitidine—Chest pain—Capecitabine—esophageal cancer	5.98e-05	0.00173	CcSEcCtD
Azacitidine—Myalgia—Capecitabine—esophageal cancer	5.98e-05	0.00173	CcSEcCtD
Azacitidine—Arthralgia—Capecitabine—esophageal cancer	5.98e-05	0.00173	CcSEcCtD
Azacitidine—Pharyngitis—Methotrexate—esophageal cancer	5.96e-05	0.00173	CcSEcCtD
Azacitidine—Anxiety—Capecitabine—esophageal cancer	5.96e-05	0.00173	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	5.94e-05	0.00172	CcSEcCtD
Azacitidine—Urinary tract disorder—Methotrexate—esophageal cancer	5.93e-05	0.00172	CcSEcCtD
Azacitidine—Discomfort—Capecitabine—esophageal cancer	5.91e-05	0.00171	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—esophageal cancer	5.89e-05	0.0017	CcSEcCtD
Azacitidine—CDA—Metabolism—GAPDH—esophageal cancer	5.82e-05	0.00217	CbGpPWpGaD
Azacitidine—Confusional state—Capecitabine—esophageal cancer	5.78e-05	0.00167	CcSEcCtD
Azacitidine—CDA—Metabolism—CRABP1—esophageal cancer	5.77e-05	0.00215	CbGpPWpGaD
Azacitidine—Oedema—Capecitabine—esophageal cancer	5.73e-05	0.00166	CcSEcCtD
Azacitidine—Hypersensitivity—Cisplatin—esophageal cancer	5.73e-05	0.00166	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—NOTCH3—esophageal cancer	5.71e-05	0.00213	CbGpPWpGaD
Azacitidine—Infection—Capecitabine—esophageal cancer	5.7e-05	0.00165	CcSEcCtD
Azacitidine—Shock—Capecitabine—esophageal cancer	5.64e-05	0.00163	CcSEcCtD
Azacitidine—Nervous system disorder—Capecitabine—esophageal cancer	5.62e-05	0.00163	CcSEcCtD
Azacitidine—Eye disorder—Methotrexate—esophageal cancer	5.61e-05	0.00163	CcSEcCtD
Azacitidine—Thrombocytopenia—Capecitabine—esophageal cancer	5.61e-05	0.00163	CcSEcCtD
Azacitidine—Tachycardia—Capecitabine—esophageal cancer	5.6e-05	0.00162	CcSEcCtD
Azacitidine—Asthenia—Cisplatin—esophageal cancer	5.58e-05	0.00162	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—esophageal cancer	5.58e-05	0.00161	CcSEcCtD
Azacitidine—Skin disorder—Capecitabine—esophageal cancer	5.57e-05	0.00161	CcSEcCtD
Azacitidine—Hyperhidrosis—Capecitabine—esophageal cancer	5.54e-05	0.0016	CcSEcCtD
Azacitidine—CDA—Metabolism—GNG7—esophageal cancer	5.48e-05	0.00205	CbGpPWpGaD
Azacitidine—Anorexia—Capecitabine—esophageal cancer	5.46e-05	0.00158	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—esophageal cancer	5.45e-05	0.00158	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—esophageal cancer	5.43e-05	0.00157	CcSEcCtD
Azacitidine—Mediastinal disorder—Methotrexate—esophageal cancer	5.41e-05	0.00157	CcSEcCtD
Azacitidine—Chills—Methotrexate—esophageal cancer	5.39e-05	0.00156	CcSEcCtD
Azacitidine—Hypotension—Capecitabine—esophageal cancer	5.36e-05	0.00155	CcSEcCtD
Azacitidine—Diarrhoea—Cisplatin—esophageal cancer	5.32e-05	0.00154	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—esophageal cancer	5.31e-05	0.00154	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—HIST1H2BM—esophageal cancer	5.27e-05	0.00197	CbGpPWpGaD
Azacitidine—Mental disorder—Methotrexate—esophageal cancer	5.26e-05	0.00152	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—esophageal cancer	5.23e-05	0.00151	CcSEcCtD
Azacitidine—Erythema—Methotrexate—esophageal cancer	5.23e-05	0.00151	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	5.22e-05	0.00151	CcSEcCtD
Azacitidine—Insomnia—Capecitabine—esophageal cancer	5.19e-05	0.0015	CcSEcCtD
Azacitidine—CDA—Metabolism—ALDH2—esophageal cancer	5.14e-05	0.00192	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NOTCH2—esophageal cancer	5.12e-05	0.00191	CbGpPWpGaD
Azacitidine—Dyspnoea—Capecitabine—esophageal cancer	5.11e-05	0.00148	CcSEcCtD
Azacitidine—Back pain—Methotrexate—esophageal cancer	5.06e-05	0.00146	CcSEcCtD
Azacitidine—Dyspepsia—Capecitabine—esophageal cancer	5.05e-05	0.00146	CcSEcCtD
Azacitidine—Decreased appetite—Capecitabine—esophageal cancer	4.98e-05	0.00144	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Capecitabine—esophageal cancer	4.95e-05	0.00143	CcSEcCtD
Azacitidine—Vomiting—Cisplatin—esophageal cancer	4.95e-05	0.00143	CcSEcCtD
Azacitidine—Fatigue—Capecitabine—esophageal cancer	4.94e-05	0.00143	CcSEcCtD
Azacitidine—Rash—Cisplatin—esophageal cancer	4.9e-05	0.00142	CcSEcCtD
Azacitidine—Constipation—Capecitabine—esophageal cancer	4.9e-05	0.00142	CcSEcCtD
Azacitidine—Pain—Capecitabine—esophageal cancer	4.9e-05	0.00142	CcSEcCtD
Azacitidine—Dermatitis—Cisplatin—esophageal cancer	4.9e-05	0.00142	CcSEcCtD
Azacitidine—CDA—Metabolism—GSTT1—esophageal cancer	4.89e-05	0.00183	CbGpPWpGaD
Azacitidine—Ill-defined disorder—Methotrexate—esophageal cancer	4.85e-05	0.0014	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—esophageal cancer	4.83e-05	0.0014	CcSEcCtD
Azacitidine—CDA—Metabolism—CYP2A6—esophageal cancer	4.83e-05	0.0018	CbGpPWpGaD
Azacitidine—Feeling abnormal—Capecitabine—esophageal cancer	4.72e-05	0.00137	CcSEcCtD
Azacitidine—Malaise—Methotrexate—esophageal cancer	4.72e-05	0.00137	CcSEcCtD
Azacitidine—Gastrointestinal pain—Capecitabine—esophageal cancer	4.69e-05	0.00136	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—esophageal cancer	4.68e-05	0.00136	CcSEcCtD
Azacitidine—Nausea—Cisplatin—esophageal cancer	4.62e-05	0.00134	CcSEcCtD
Azacitidine—CDA—Metabolism—ENO1—esophageal cancer	4.58e-05	0.00171	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTGS1—esophageal cancer	4.58e-05	0.00171	CbGpPWpGaD
Azacitidine—Cough—Methotrexate—esophageal cancer	4.56e-05	0.00132	CcSEcCtD
Azacitidine—Urticaria—Capecitabine—esophageal cancer	4.55e-05	0.00132	CcSEcCtD
Azacitidine—Abdominal pain—Capecitabine—esophageal cancer	4.53e-05	0.00131	CcSEcCtD
Azacitidine—Body temperature increased—Capecitabine—esophageal cancer	4.53e-05	0.00131	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—esophageal cancer	4.53e-05	0.00131	CcSEcCtD
Azacitidine—CDA—Metabolism—PSME1—esophageal cancer	4.51e-05	0.00169	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PSME2—esophageal cancer	4.51e-05	0.00169	CbGpPWpGaD
Azacitidine—Chest pain—Methotrexate—esophageal cancer	4.45e-05	0.00129	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—esophageal cancer	4.45e-05	0.00129	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—esophageal cancer	4.45e-05	0.00129	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	4.42e-05	0.00128	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—esophageal cancer	4.4e-05	0.00127	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—esophageal cancer	4.3e-05	0.00125	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—SMAD4—esophageal cancer	4.3e-05	0.00161	CbGpPWpGaD
Azacitidine—Anaphylactic shock—Methotrexate—esophageal cancer	4.27e-05	0.00124	CcSEcCtD
Azacitidine—Adenosine triphosphate—ABCB1—esophageal cancer	4.26e-05	0.0573	CrCbGaD
Azacitidine—Infection—Methotrexate—esophageal cancer	4.24e-05	0.00123	CcSEcCtD
Azacitidine—Hypersensitivity—Capecitabine—esophageal cancer	4.22e-05	0.00122	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—esophageal cancer	4.19e-05	0.00121	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—esophageal cancer	4.18e-05	0.00121	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—esophageal cancer	4.15e-05	0.0012	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—esophageal cancer	4.13e-05	0.00119	CcSEcCtD
Azacitidine—Asthenia—Capecitabine—esophageal cancer	4.11e-05	0.00119	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—PSME1—esophageal cancer	4.09e-05	0.00153	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PSME2—esophageal cancer	4.09e-05	0.00153	CbGpPWpGaD
Azacitidine—Anorexia—Methotrexate—esophageal cancer	4.07e-05	0.00118	CcSEcCtD
Azacitidine—Pruritus—Capecitabine—esophageal cancer	4.06e-05	0.00117	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—esophageal cancer	3.99e-05	0.00115	CcSEcCtD
Azacitidine—Diarrhoea—Capecitabine—esophageal cancer	3.92e-05	0.00114	CcSEcCtD
Azacitidine—CDA—Metabolism—CYP1B1—esophageal cancer	3.9e-05	0.00145	CbGpPWpGaD
Azacitidine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	3.89e-05	0.00113	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—esophageal cancer	3.86e-05	0.00112	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—NOTCH3—esophageal cancer	3.86e-05	0.00144	CbGpPWpGaD
Azacitidine—Dyspnoea—Methotrexate—esophageal cancer	3.8e-05	0.0011	CcSEcCtD
Azacitidine—Dizziness—Capecitabine—esophageal cancer	3.79e-05	0.0011	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—esophageal cancer	3.76e-05	0.00109	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—esophageal cancer	3.71e-05	0.00107	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—esophageal cancer	3.68e-05	0.00107	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—esophageal cancer	3.68e-05	0.00107	CcSEcCtD
Azacitidine—CDA—Metabolism—CYP19A1—esophageal cancer	3.66e-05	0.00137	CbGpPWpGaD
Azacitidine—Pain—Methotrexate—esophageal cancer	3.65e-05	0.00106	CcSEcCtD
Azacitidine—Vomiting—Capecitabine—esophageal cancer	3.65e-05	0.00106	CcSEcCtD
Azacitidine—Rash—Capecitabine—esophageal cancer	3.61e-05	0.00105	CcSEcCtD
Azacitidine—Dermatitis—Capecitabine—esophageal cancer	3.61e-05	0.00105	CcSEcCtD
Azacitidine—Headache—Capecitabine—esophageal cancer	3.59e-05	0.00104	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—esophageal cancer	3.52e-05	0.00102	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—esophageal cancer	3.49e-05	0.00101	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—NOTCH2—esophageal cancer	3.46e-05	0.00129	CbGpPWpGaD
Azacitidine—Nausea—Capecitabine—esophageal cancer	3.41e-05	0.000986	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—esophageal cancer	3.39e-05	0.000982	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—esophageal cancer	3.37e-05	0.000977	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—esophageal cancer	3.37e-05	0.000977	CcSEcCtD
Azacitidine—CDA—Metabolism—HMOX1—esophageal cancer	3.34e-05	0.00125	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ABCB1—esophageal cancer	3.21e-05	0.0012	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NOTCH1—esophageal cancer	3.17e-05	0.00118	CbGpPWpGaD
Azacitidine—Hypersensitivity—Methotrexate—esophageal cancer	3.14e-05	0.00091	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—esophageal cancer	3.06e-05	0.000887	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—esophageal cancer	3.02e-05	0.000874	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—esophageal cancer	2.92e-05	0.000845	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—SMAD4—esophageal cancer	2.91e-05	0.00109	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—CREBBP—esophageal cancer	2.88e-05	0.00107	CbGpPWpGaD
Azacitidine—Dizziness—Methotrexate—esophageal cancer	2.82e-05	0.000817	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—esophageal cancer	2.71e-05	0.000786	CcSEcCtD
Azacitidine—Rash—Methotrexate—esophageal cancer	2.69e-05	0.000779	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—esophageal cancer	2.69e-05	0.000778	CcSEcCtD
Azacitidine—Headache—Methotrexate—esophageal cancer	2.67e-05	0.000774	CcSEcCtD
Azacitidine—Nausea—Methotrexate—esophageal cancer	2.54e-05	0.000734	CcSEcCtD
Azacitidine—CDA—Metabolism—CREBBP—esophageal cancer	2.14e-05	0.000801	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NOTCH1—esophageal cancer	2.14e-05	0.0008	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—CREBBP—esophageal cancer	1.94e-05	0.000725	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NOS3—esophageal cancer	1.92e-05	0.000717	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTGS2—esophageal cancer	1.76e-05	0.000656	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MYC—esophageal cancer	1.71e-05	0.000637	CbGpPWpGaD
Azacitidine—CDA—Metabolism—EP300—esophageal cancer	1.46e-05	0.000545	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MYC—esophageal cancer	1.15e-05	0.000431	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3CA—esophageal cancer	1.08e-05	0.000403	CbGpPWpGaD
